Lung Transplantation in Respiratory Failure Patients
This trial is active, not recruiting.
|Sponsor||National Taiwan University Hospital|
|Start date||February 2009|
|End date||April 2009|
|Trial size||10 participants|
|Trial identifier||NCT00854165, 200901015R|
Survival after cadaveric lung transplantation in recipients depended on ventilation support prior to transplantation has been reported to have relative high surgical mortality and morbidity rate. The objectives of this study were to describe the short-term outcomes of bilateral sequential lung transplantation under extracorporeal membrane oxygenation (ECMO) support in a consecutive series of patients who depended on noninvasive and invasive ventilation support preoperatively .
|Observational model||case control|
6 months and one year survival after lung transplatn.
time frame: 6 months and one year posttransplant
Pulmonary function results, at baseline and posttransplant 1, 3, and 6 months.
time frame: baseline, post-op 1,3, and 6 months
Male or female participants of any age.
Inclusion Criteria: - respiratory patients depended on ventilator supports prior to lung transplant Exclusion Criteria: - non-cardaveric lung transplant
|Official title||Extracorporeal Membrane Oxygenation Support for Bilateral Sequential Lung Transplantation in Respiratory Failure Patients.|
|Principal investigator||Hsao-Hsun Hsu, MD|
|Description||The one-year survival rate and postoperative pulmonary functional results will be reported in this study.|
Call for more information